Arimoclomol is an investigational pyridine carboximidoyl chloride derivative developed as a potential therapeutic agent for treating conditions such as obsessive-compulsive disorder by modulating serotonin… Read more







Arimoclomol is an investigational pyridine carboximidoyl chloride derivative developed as a potential therapeutic agent for treating conditions such as obsessive-compulsive disorder by modulating serotonin receptors to mitigate compulsive behaviors. This category provides a comprehensive selection of high-quality reference standards, including the active pharmaceutical ingredient, related pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. Pharmaceutical laboratories and analytical research facilities utilize these compounds to support rigorous impurity profiling, method validation, and quality control procedures. The inclusion of stable isotope labelled compounds, such as deuterium-labelled variants, further assists researchers in performing precise quantitative analysis and complex pharmacokinetic studies. By supplying these essential materials, analytical workflows can maintain the high accuracy and reproducibility required for evaluating the development and stability of this experimental pharmaceutical throughout the research and regulatory process.